RhumbLine Advisers
CALT

RhumbLine Advisers’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

RhumbLine Advisers’s Portfolio CALT Stock Details CALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
2024
Q3 		$12.2K Buy
2024
Q2 		$7.87K Buy
2024
Q1 		$3.55K Hold
2023
Q4 		$4.22K Buy
2023
Q3 		$2.72K Buy
2023
Q2 		$2.18K Buy